other material
confidence high
sentiment neutral
materiality 0.60
CalciMedica stockholders approve reverse split, 7.5M-share plan increase, warrant issuances
CalciMedica, Inc.
- Approved reverse stock split at ratio between 1-for-2 and 1-for-10, with corresponding reduction in authorized shares; board to set timing and ratio.
- Equity plan amended to increase shares by 7,500,000; annual auto reserve now includes shares from convertible preferred and pre-funded warrants.
- Elected Allan Shaw and Robert N. Wilson as Class III directors for three-year terms.
- Approved issuance of up to 18,673,429 shares under Series A/B warrants (Rule 5635(d)) and 1,680,565 each for officers/directors (Rule 5635(c)).
- Say-on-pay advisory vote passed; frequency of one year, with next vote no later than 2032 annual meeting.